Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

Overview of attention for article published in Clinical and Translational Allergy, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 17,660 followers.

RT @EAACI_HQ: Sleep improvement with #omalizumab in patients with chronic #urticaria #CTA_Journal https://t.co/luL5dSTXER https://t.co/F…

Reply Repost Favourite

RT @UrticariaCronic: Mejora del sueño con omalizumab en pacientes con #urticaria crónica https://t.co/oAD7x0VRvH (en inglés) vía @EAACI_HQ

Reply Repost Favourite

RT @UrticariaCronic: Mejora del sueño con omalizumab en pacientes con #urticaria crónica https://t.co/oAD7x0VRvH (en inglés) vía @EAACI_HQ

Reply Repost Favourite

RT @UrticariaCronic: Mejora del sueño con omalizumab en pacientes con #urticaria crónica https://t.co/oAD7x0VRvH (en inglés) vía @EAACI_HQ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.